Companies
RNS
Signals
Macro
AI Chat
Research
Indices
Ticker TV
Events
Commodities
Currencies
Footer menu
⌘K
Open sidebar
Developer Portal
News
Services
Iq-Ai Limited (IQAI) RNS Announcements | Ticker
/
Equities
/
XLON
/
IQAI
/
RNS
Former ticker.
Iq-Ai Limited now trades as
IBAI
(IMAGING BIOMETRICS LIMITED).
Overview
Share Price
RNS
Trades
Short Interest
Directors
Holdings
Iq-Ai Limited RNS
/
Equities
/
XLON
/
IQAI
/
RNS
Former ticker.
Iq-Ai Limited now trades as
IBAI
(IMAGING BIOMETRICS LIMITED).
Overview
Share Price
RNS
Trades
Short Interest
Directors
Holdings
Iq-Ai Limited RNS
Add to watchlist
Date
Time
Date
Title
Title
(filtered)
08/09/23
07:00:04
8 Sept 2023
Reduced Gadolinium Approach Validated'
Reduced Gadolinium Approach Validated'
18/08/23
12:06:19
18 Aug 2023
Update on Collaboration Agreement with Mayo Clinic
Update on Collaboration Agreement with Mayo Clinic
18/08/23
11:20:55
18 Aug 2023
IB & GE HealthCare Enter into Commercial Agreement
IB & GE HealthCare Enter into Commercial Agreement
17/08/23
07:00:02
17 Aug 2023
Half-year Report
Half-year Report
19/07/23
07:00:05
19 Jul 2023
Imaging Biometrics Installs IB Nimble™ For MCW
Imaging Biometrics Installs IB Nimble™ For MCW
13/07/23
07:00:03
13 Jul 2023
Orphan Drug Designation for GaM in Pediatric GBM
Orphan Drug Designation for GaM in Pediatric GBM
27/06/23
07:00:06
27 Jun 2023
Studies Show GaM Inhibits Pediatric Tumor Growth
Studies Show GaM Inhibits Pediatric Tumor Growth
23/05/23
11:02:53
23 May 2023
Result of AGM
Result of AGM
23/05/23
07:00:01
23 May 2023
AGM Statement
AGM Statement
03/05/23
16:14:48
3 May 2023
Notice of AGM
Notice of AGM
26/04/23
07:00:10
26 Apr 2023
Final Results
Final Results
28/02/23
15:52:30
28 Feb 2023
Orphan Drug Designation Status
Orphan Drug Designation Status
13/01/23
14:05:23
13 Jan 2023
Second Price Monitoring Extn
Second Price Monitoring Extn
13/01/23
14:00:10
13 Jan 2023
Price Monitoring Extension
Price Monitoring Extension
13/01/23
11:05:26
13 Jan 2023
Second Price Monitoring Extn
Second Price Monitoring Extn
13/01/23
11:00:12
13 Jan 2023
Price Monitoring Extension
Price Monitoring Extension
10/01/23
07:00:02
10 Jan 2023
Letter to Shareholders
Letter to Shareholders
02/12/22
11:11:59
2 Dec 2022
Holding in Company
Holding in Company
25/10/22
11:00:16
25 Oct 2022
Price Monitoring Extension
Price Monitoring Extension
30/09/22
07:00:10
30 Sept 2022
Letter to Shareholders
Letter to Shareholders
26/09/22
07:00:12
26 Sept 2022
Issue of Warrants to Employees
Issue of Warrants to Employees
16/08/22
16:40:40
16 Aug 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
16/08/22
16:35:39
16 Aug 2022
Price Monitoring Extension
Price Monitoring Extension
16/08/22
09:28:44
16 Aug 2022
Half-year Report
Half-year Report
03/08/22
13:01:00
3 Aug 2022
TR1 - Notification of Major Holdings
TR1 - Notification of Major Holdings
11/07/22
07:00:05
11 Jul 2022
Imaging Biometrics Announces Channel Partnership
Imaging Biometrics Announces Channel Partnership
31/05/22
11:05:43
31 May 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
31/05/22
11:00:27
31 May 2022
Price Monitoring Extension
Price Monitoring Extension
31/05/22
08:00:01
31 May 2022
Submission of FDA 510(k) Application for IB Zero G
Submission of FDA 510(k) Application for IB Zero G
30/05/22
10:47:05
30 May 2022
Result of AGM
Result of AGM
05/05/22
15:00:06
5 May 2022
Notice of AGM
Notice of AGM
03/05/22
14:21:42
3 May 2022
IB Broadens Quantitative Mapping
IB Broadens Quantitative Mapping
28/04/22
17:52:43
28 Apr 2022
Final Results
Final Results
09/03/22
15:08:18
9 Mar 2022
IQAI’s Sponsored Phase I Clinical Trial is Open
IQAI’s Sponsored Phase I Clinical Trial is Open
28/02/22
11:12:38
28 Feb 2022
Total Voting Rights
Total Voting Rights
08/02/22
07:00:02
8 Feb 2022
Issue of shares to Mayo Clinic
Issue of shares to Mayo Clinic
27/01/22
07:00:07
27 Jan 2022
Imaging Biometrics LLC - Letter to Shareholders
Imaging Biometrics LLC - Letter to Shareholders
04/01/22
09:27:40
4 Jan 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
17/12/21
07:37:40
17 Dec 2021
IQ-AI Prepares for Phase I Clinical Trial Launch
IQ-AI Prepares for Phase I Clinical Trial Launch
13/12/21
10:32:46
13 Dec 2021
Director's Interest
Director's Interest
11/11/21
08:52:14
11 Nov 2021
Agreement with St. Jude Children’s Hospital
Agreement with St. Jude Children’s Hospital
02/11/21
08:19:37
2 Nov 2021
MD ANDERSON ADOPTS IB CLINIC
MD ANDERSON ADOPTS IB CLINIC
28/10/21
16:00:45
28 Oct 2021
Letter to Shareholders
Letter to Shareholders
07/10/21
16:41:50
7 Oct 2021
Second Price Monitoring Extn
Second Price Monitoring Extn
07/10/21
16:36:25
7 Oct 2021
Price Monitoring Extension
Price Monitoring Extension
07/10/21
14:05:54
7 Oct 2021
Second Price Monitoring Extn
Second Price Monitoring Extn
07/10/21
14:00:54
7 Oct 2021
Price Monitoring Extension
Price Monitoring Extension
07/10/21
12:00:00
7 Oct 2021
Placing
Placing
01/10/21
08:17:36
1 Oct 2021
Case Report on Clinical Value of IB Software
Case Report on Clinical Value of IB Software
22/09/21
07:00:03
22 Sept 2021
EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
Showing 51–100 of 105 announcements
Previous
1
2
3
Next
Date
Time
Date
Title
Title
(filtered)
08/09/23
07:00:04
8 Sept 2023
Reduced Gadolinium Approach Validated'
Reduced Gadolinium Approach Validated'
18/08/23
12:06:19
18 Aug 2023
Update on Collaboration Agreement with Mayo Clinic
Update on Collaboration Agreement with Mayo Clinic
18/08/23
11:20:55
18 Aug 2023
IB & GE HealthCare Enter into Commercial Agreement
IB & GE HealthCare Enter into Commercial Agreement
17/08/23
07:00:02
17 Aug 2023
Half-year Report
Half-year Report
19/07/23
07:00:05
19 Jul 2023
Imaging Biometrics Installs IB Nimble™ For MCW
Imaging Biometrics Installs IB Nimble™ For MCW
13/07/23
07:00:03
13 Jul 2023
Orphan Drug Designation for GaM in Pediatric GBM
Orphan Drug Designation for GaM in Pediatric GBM
27/06/23
07:00:06
27 Jun 2023
Studies Show GaM Inhibits Pediatric Tumor Growth
Studies Show GaM Inhibits Pediatric Tumor Growth
23/05/23
11:02:53
23 May 2023
Result of AGM
Result of AGM
23/05/23
07:00:01
23 May 2023
AGM Statement
AGM Statement
03/05/23
16:14:48
3 May 2023
Notice of AGM
Notice of AGM
26/04/23
07:00:10
26 Apr 2023
Final Results
Final Results
28/02/23
15:52:30
28 Feb 2023
Orphan Drug Designation Status
Orphan Drug Designation Status
13/01/23
14:05:23
13 Jan 2023
Second Price Monitoring Extn
Second Price Monitoring Extn
13/01/23
14:00:10
13 Jan 2023
Price Monitoring Extension
Price Monitoring Extension
13/01/23
11:05:26
13 Jan 2023
Second Price Monitoring Extn
Second Price Monitoring Extn
13/01/23
11:00:12
13 Jan 2023
Price Monitoring Extension
Price Monitoring Extension
10/01/23
07:00:02
10 Jan 2023
Letter to Shareholders
Letter to Shareholders
02/12/22
11:11:59
2 Dec 2022
Holding in Company
Holding in Company
25/10/22
11:00:16
25 Oct 2022
Price Monitoring Extension
Price Monitoring Extension
30/09/22
07:00:10
30 Sept 2022
Letter to Shareholders
Letter to Shareholders
26/09/22
07:00:12
26 Sept 2022
Issue of Warrants to Employees
Issue of Warrants to Employees
16/08/22
16:40:40
16 Aug 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
16/08/22
16:35:39
16 Aug 2022
Price Monitoring Extension
Price Monitoring Extension
16/08/22
09:28:44
16 Aug 2022
Half-year Report
Half-year Report
03/08/22
13:01:00
3 Aug 2022
TR1 - Notification of Major Holdings
TR1 - Notification of Major Holdings
11/07/22
07:00:05
11 Jul 2022
Imaging Biometrics Announces Channel Partnership
Imaging Biometrics Announces Channel Partnership
31/05/22
11:05:43
31 May 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
31/05/22
11:00:27
31 May 2022
Price Monitoring Extension
Price Monitoring Extension
31/05/22
08:00:01
31 May 2022
Submission of FDA 510(k) Application for IB Zero G
Submission of FDA 510(k) Application for IB Zero G
30/05/22
10:47:05
30 May 2022
Result of AGM
Result of AGM
05/05/22
15:00:06
5 May 2022
Notice of AGM
Notice of AGM
03/05/22
14:21:42
3 May 2022
IB Broadens Quantitative Mapping
IB Broadens Quantitative Mapping
28/04/22
17:52:43
28 Apr 2022
Final Results
Final Results
09/03/22
15:08:18
9 Mar 2022
IQAI’s Sponsored Phase I Clinical Trial is Open
IQAI’s Sponsored Phase I Clinical Trial is Open
28/02/22
11:12:38
28 Feb 2022
Total Voting Rights
Total Voting Rights
08/02/22
07:00:02
8 Feb 2022
Issue of shares to Mayo Clinic
Issue of shares to Mayo Clinic
27/01/22
07:00:07
27 Jan 2022
Imaging Biometrics LLC - Letter to Shareholders
Imaging Biometrics LLC - Letter to Shareholders
04/01/22
09:27:40
4 Jan 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
17/12/21
07:37:40
17 Dec 2021
IQ-AI Prepares for Phase I Clinical Trial Launch
IQ-AI Prepares for Phase I Clinical Trial Launch
13/12/21
10:32:46
13 Dec 2021
Director's Interest
Director's Interest
11/11/21
08:52:14
11 Nov 2021
Agreement with St. Jude Children’s Hospital
Agreement with St. Jude Children’s Hospital
02/11/21
08:19:37
2 Nov 2021
MD ANDERSON ADOPTS IB CLINIC
MD ANDERSON ADOPTS IB CLINIC
28/10/21
16:00:45
28 Oct 2021
Letter to Shareholders
Letter to Shareholders
07/10/21
16:41:50
7 Oct 2021
Second Price Monitoring Extn
Second Price Monitoring Extn
07/10/21
16:36:25
7 Oct 2021
Price Monitoring Extension
Price Monitoring Extension
07/10/21
14:05:54
7 Oct 2021
Second Price Monitoring Extn
Second Price Monitoring Extn
07/10/21
14:00:54
7 Oct 2021
Price Monitoring Extension
Price Monitoring Extension
07/10/21
12:00:00
7 Oct 2021
Placing
Placing
01/10/21
08:17:36
1 Oct 2021
Case Report on Clinical Value of IB Software
Case Report on Clinical Value of IB Software
22/09/21
07:00:03
22 Sept 2021
EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
Showing 51–100 of 105 announcements
Previous
1
2
3
Next